Skip to content
Screener

Natera, Inc. NTRA Common Stock

Common Stock at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
150M0.0%
Labcorp Holdings logo
Labcorp HoldingsLH
265M0.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2M0.0%
NeoGenomics logo
NeoGenomicsNEO
$130K+1.6%
Illumina logo
IlluminaILMN
$2M0.0%
CareDx logo
CareDxCDNA
100M0.0%

Other financials

Income statement

See full
Revenue$752.8M+37.7%
Operating income-$75.8M+31.3%
Net income-$67.0M+33.7%
EPS (diluted)-$0.47+36.5%

Balance sheet

See full
Cash & equivalents$1.1B+9.1%
Total debt$238.5M+21.6%
Total equity$1.8B+46.2%
Total assets$2.7B+51.2%

Cash flow

See full
Operating cash flow$54.8M+45.8%
CapEx$63.4M+145%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$46.43B+115%
Enterprise value$45.58B+120%
P/S17.2×+6.2×

Profitability

See full
Gross margin42.9%
Operating margin-10.7%-2.4pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.7×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: Natera, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054525
Line itemJune 30,2026December 31,2025
Total liabilities835,998685,931
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both June 30, 2026 and December 31, 2025; 143,612 and 139,693 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively1414
Additional paid-in capital4,749,6754,488,679
Accumulated deficit(2,928,082)(2,776,022)
Accumulated other comprehensive loss(108)(258)
Total stockholders’ equity1,821,4991,712,413

Item 1. Financial Statements (unaudited)

FAQ

What is Natera, Inc.'s common stock?
Natera, Inc. (NTRA) reported common stock of 750M in Q2 2026.
How has Natera, Inc.'s common stock changed year-over-year?
Natera, Inc.'s common stock increased by 5357042.9% year-over-year, from 14K to 750M.
What is the long-term trend for Natera, Inc.'s common stock?
Over 5 years (2020 to 2025), Natera, Inc.'s common stock has grown at a 864.2% compound annual growth rate (CAGR), from 9K to 750M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Natera, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude